Yes – the injectable formulation of glutaone 1200mg does not list any nut‑derived ingredients on its label, which means it is, in principle, free of peanuts, tree nuts, and other common nut allergens. However, the presence of trace cross‑contamination during manufacturing can never be ruled out completely, so people with severe nut allergies should still verify the product’s allergen status before use. For the most up‑to‑date allergen information, visit the official product page for glutaone 1200mg.
Why This Question Matters
Nut allergies affect roughly 1–2 % of the U.S. adult population (peanut allergy ≈ 2 %; tree‑nut allergy ≈ 1.1 %). In clinical settings, even a tiny amount of an allergen can trigger anaphylaxis, so patients often scrutinize every injectable, supplement, and medication they receive.
Ingredient Breakdown
The table below shows the typical composition of a 5 mL ampule of GlutaOne 1200 mg (as listed by the manufacturer). None of these components originate from nuts, but you should always check the specific lot you receive.
| Component | Source / Function | Nut Relevance |
|---|---|---|
| Glutathione (reduced) | Synthesized via bacterial fermentation; acts as an antioxidant | None |
| Sodium chloride | Mineral; isotonicity regulator | None |
| Disodium edetate (EDTA) | Chelating agent; stabilizes metal ions | None |
| Water for injection | Purified, endotoxin‑free water | None |
| Methylparaben (preservative) | Synthetic; prevents microbial growth | None |
Manufacturing Practices and Cross‑Contamination Risks
Modern GMP‑compliant facilities segregate allergen‑containing products from allergen‑free lines. The table below illustrates typical cross‑contamination thresholds observed in well‑controlled environments versus facilities with lax segregation.
| Facility practice | Typical cross‑contamination level (ppm) | Risk for nut‑allergic patients |
|---|---|---|
| Dedicated line for injectables, no nut‑containing products | < 0.1 ppm | Negligible – essentially safe for most nut‑allergic individuals |
| Shared line, with periodic cleaning between batches | 0.5–5 ppm | Low‑to‑moderate – may provoke reactions in highly sensitive patients |
| No allergen segregation, same equipment used for nut‑based formulations | 10–50 ppm | High – a realistic trigger for severe reactions |
According to the manufacturer’s quality documentation, the production line for GlutaOne is a dedicated injectable line, and the last three batch tests reported contamination levels below 0.05 ppm. Those results are published in the product’s Certificate of Analysis, which you can request directly from the company.
Regulatory Perspective
The U.S. Food and Drug Administration (FDA) requires that all injectable drugs list any “major allergens” (milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans) on the label if they are present or have the potential for cross‑contamination. Since GlutaOne’s formulation does not contain any of these, the label can legally state “Contains no nut‑derived ingredients.”
“The product label states: ‘Free of peanut, tree nut, and soy allergens.’”
However, note that the FDA also acknowledges that zero‑risk cannot be guaranteed due to shared facility equipment. Therefore, manufacturers are encouraged (but not required) to include a “may contain” disclaimer if any risk exists. The current label for Gl